Pub. Date : 2021 Apr
PMID : 33528846
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | KEY POINTS: This report demonstrates remarkable response for KRAS-mutated, ER-positive low-grade serous ovarian cancer patient treated with trametinib (MEK inhibitor) and letrozole (aromatase inhibitor), despite prior progression on similar agents including tamoxifen (estrogen modulator). | Tamoxifen | epiregulin | Homo sapiens |